Acuis Daily is written by AI based on official sources. It may contain errors or omissions. Acuis Daily is for information purposes only. It is not legal or professional advice. Always check the official source before relying on an entry.
6 Nov 2026
/
Commission
/
Implementing rule
Committee publishes voting results on Innovax-ND-H5 vaccine authorisation amendment
The Standing Committee on veterinary medicinal products published voting results on a draft Commission implementing decision amending the marketing authorisation granted in exceptional circumstances for Innovax-ND-H5, a live recombinant avian influenza vaccine. The item does not specify the voting outcome.
Importance
Routine
Lenses
Regulatory
Why it matters
This is a procedural step concerning an amendment to one veterinary vaccine’s marketing authorisation.
Institutions
CommissionStanding Committee on veterinary medicinal products
Audience
Regulatory affairs teams
Tags
Health
Sectors
Pharmaceuticals
References
- Commission decision: C(2024) 3549
- Comitology meeting: CMTD(2026)1750